Brainsway
Zafiris ‘Jeff’ Daskalakis is the Chair of the Department of Psychiatry at UC San Diego. He was formerly the Temerty Chair and Chief of the General Adult Psychiatry at CAMH.
His research focuses on neurophysiological and treatment studies using repetitive transcranial magnetic brain stimulation (rTMS) and magnetic seizure therapy (MST).
He established Canada’s first TMS clinical training program and holds or has held numerous federal operating grants and awards, including grants from the NIH and CIHR. He has received over $50 million in research funding as a principal investigator, has over 450 peer-reviewed publications, and is an editorial board member for Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, and an Associate Editor for Clinical Neurophysiology.
He is also a member of the Brain and Behavior Research Foundation (formerly NARSAD) Scientific Council.
This person is not in the org chart
This person is not in any offices
Brainsway
Brainsway is an Israeli company with international operations that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a noninvasive treatment for depression.